Why The FDA’s ‘Breakthrough’ Nomination For MDMA Matters - Psychedelic Times

MDMA photo via Flickr user Kripos_NCIS You may have heard that the U.S. Food and Drug Administration recently designated MDMA a ‘breakthrough therapy’—but what the heck does that mean?   Currently, the Multidisciplinary Association for Psychedelic Studies is studying MDMA for its usefulness in treating extreme post-traumatic stress disorder (PTSD) in conjunction with psychotherapy. They are …
Read more: https://psychedelictimes.com/mdma/fdas-breakthrough-nomination-mdma-matters/?source=Snapzu